Antipyretic effect of central [Pyr1]apelin13 on LPS-induced fever in the rat

Intracerebroventricular (i.c.v.) injections of apelins have been shown to modulate the central control of cardiovascular function, as well as the homeostasis of fluid and salt balance, and to some extent also body core temperature. Here, we investigated the effects of i.c.v. administration of [Pyr1]...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Regulatory peptides 2013-06, Vol.184, p.6-13
Hauptverfasser: Hatzelmann, Thomas, Harden, Lois M., Roth, Joachim, Gerstberger, Rüdiger
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 13
container_issue
container_start_page 6
container_title Regulatory peptides
container_volume 184
creator Hatzelmann, Thomas
Harden, Lois M.
Roth, Joachim
Gerstberger, Rüdiger
description Intracerebroventricular (i.c.v.) injections of apelins have been shown to modulate the central control of cardiovascular function, as well as the homeostasis of fluid and salt balance, and to some extent also body core temperature. Here, we investigated the effects of i.c.v. administration of [Pyr1]apelin13 (PyrAp13; 20nmol) dissolved in artificial cerebrospinal fluid (aCSF), as compared to aCSF alone, on fever and sickness behavior elicited in rats by intraperitoneal injection of bacterial lipopolysaccharide (LPS, 100μg/kg). Injections of LPS induced a short phase of hypothermia followed by a biphasic fever, depression of motor activity, anorexia and adipsia. I.c.v. injections of PyrAp13 without systemic LPS application slightly augmented motor activity at statistically unaltered core temperature. In combination with LPS, central administration of PyrAp13 significantly reduced fever during the time period of 3–9h after injection, but did not significantly attenuate anorexia and adipsia, and had no effect on LPS-induced lethargy. Rats injected with PyrAp13 along with LPS showed a reduced level of LPS-induced circulating tumor necrosis factor-α (TNF-α). Primary neuroglial cultures established from the hypothalamic paraventricular nucleus (PVN) and the median preoptic nucleus (MnPO), brain sites being of major importance for central thermoregulation and also expressing the apelin receptor, were incubated with medium alone, medium containing LPS (100μg/ml) or LPS plus PyrAp13 (10−6mol/L). Ninety minutes after start of the incubation, LPS alone but not LPS in combination with PyrAp13 (10−6mol/L) caused a significant elevation of TNF-α in the supernatants. The novel observation that PyrAp13 represents a centrally acting endogenous antipyretic peptide is discussed in relation to its capacity to modulate peripheral and central formation of TNF-α. •Centrally applied [Pyr1]apelin13 attenuates LPS-induced fever in rats.•Centrally applied [Pyr1]apelin13 does not modulate food and water intake.•Centrally applied [Pyr1]apelin13 reduces LPS-induced circulating TNF-α.•Pyr1apelin13 reduces LPS-induced TNF-α release in hypothalamic microcultures.
doi_str_mv 10.1016/j.regpep.2013.03.018
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1353044098</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0167011513000475</els_id><sourcerecordid>1353044098</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-395e17eec09fb92f79019cb7d96bed6de57a4c0e703253903e5eb2c01275e5f63</originalsourceid><addsrcrecordid>eNp9kE1Lw0AQhhdRbK3-A5E9ekmdyXazyUUoxS8oWFBPIkuymdUtaRJ300L_vSmtHoWBuTzvvMzD2CXCGAGTm-XY02dL7TgGFGPoB9MjNsRUiQiTNDlmwx5TESDKATsLYQmAUilxygaxkACpkEM2n9ada7eeOmc4WUum443lhurO5xV_X2w9fuQtVa5GwZuazxcvkavLtaGSW9qQ567m3Rdxn3fn7MTmVaCLwx6xt_u719ljNH9-eJpN55ERSdxFIpOEishAZosstioDzEyhyiwpqExKkiqfGCAFIpYiA0GSitgAxkqStIkYsev93dY332sKnV65YKiq8pqaddAopIDJBLK0Ryd71PgmBE9Wt96tcr_VCHrnUS_13qPeedTQD-5iV4eGdbGi8i_0K64HbvcA9X9uHHkdjKO6t-J871CXjfu_4QdG44R7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1353044098</pqid></control><display><type>article</type><title>Antipyretic effect of central [Pyr1]apelin13 on LPS-induced fever in the rat</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hatzelmann, Thomas ; Harden, Lois M. ; Roth, Joachim ; Gerstberger, Rüdiger</creator><creatorcontrib>Hatzelmann, Thomas ; Harden, Lois M. ; Roth, Joachim ; Gerstberger, Rüdiger</creatorcontrib><description>Intracerebroventricular (i.c.v.) injections of apelins have been shown to modulate the central control of cardiovascular function, as well as the homeostasis of fluid and salt balance, and to some extent also body core temperature. Here, we investigated the effects of i.c.v. administration of [Pyr1]apelin13 (PyrAp13; 20nmol) dissolved in artificial cerebrospinal fluid (aCSF), as compared to aCSF alone, on fever and sickness behavior elicited in rats by intraperitoneal injection of bacterial lipopolysaccharide (LPS, 100μg/kg). Injections of LPS induced a short phase of hypothermia followed by a biphasic fever, depression of motor activity, anorexia and adipsia. I.c.v. injections of PyrAp13 without systemic LPS application slightly augmented motor activity at statistically unaltered core temperature. In combination with LPS, central administration of PyrAp13 significantly reduced fever during the time period of 3–9h after injection, but did not significantly attenuate anorexia and adipsia, and had no effect on LPS-induced lethargy. Rats injected with PyrAp13 along with LPS showed a reduced level of LPS-induced circulating tumor necrosis factor-α (TNF-α). Primary neuroglial cultures established from the hypothalamic paraventricular nucleus (PVN) and the median preoptic nucleus (MnPO), brain sites being of major importance for central thermoregulation and also expressing the apelin receptor, were incubated with medium alone, medium containing LPS (100μg/ml) or LPS plus PyrAp13 (10−6mol/L). Ninety minutes after start of the incubation, LPS alone but not LPS in combination with PyrAp13 (10−6mol/L) caused a significant elevation of TNF-α in the supernatants. The novel observation that PyrAp13 represents a centrally acting endogenous antipyretic peptide is discussed in relation to its capacity to modulate peripheral and central formation of TNF-α. •Centrally applied [Pyr1]apelin13 attenuates LPS-induced fever in rats.•Centrally applied [Pyr1]apelin13 does not modulate food and water intake.•Centrally applied [Pyr1]apelin13 reduces LPS-induced circulating TNF-α.•Pyr1apelin13 reduces LPS-induced TNF-α release in hypothalamic microcultures.</description><identifier>ISSN: 0167-0115</identifier><identifier>EISSN: 1873-1686</identifier><identifier>DOI: 10.1016/j.regpep.2013.03.018</identifier><identifier>PMID: 23500835</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Animals ; Antipyresis ; Antipyretics - pharmacology ; Antipyretics - therapeutic use ; Apelin ; Cytokines ; Fever ; Fever - drug therapy ; Fever - metabolism ; Fever - physiopathology ; Hypothalamus ; Injections, Intraperitoneal ; Intercellular Signaling Peptides and Proteins - pharmacology ; Intercellular Signaling Peptides and Proteins - therapeutic use ; Lipopolysaccharides - pharmacology ; Male ; Paraventricular Hypothalamic Nucleus - metabolism ; Rats ; Sickness behavior ; Tumor Necrosis Factor-alpha - metabolism</subject><ispartof>Regulatory peptides, 2013-06, Vol.184, p.6-13</ispartof><rights>2013 Elsevier B.V.</rights><rights>Copyright © 2013 Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-395e17eec09fb92f79019cb7d96bed6de57a4c0e703253903e5eb2c01275e5f63</citedby><cites>FETCH-LOGICAL-c362t-395e17eec09fb92f79019cb7d96bed6de57a4c0e703253903e5eb2c01275e5f63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.regpep.2013.03.018$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23500835$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hatzelmann, Thomas</creatorcontrib><creatorcontrib>Harden, Lois M.</creatorcontrib><creatorcontrib>Roth, Joachim</creatorcontrib><creatorcontrib>Gerstberger, Rüdiger</creatorcontrib><title>Antipyretic effect of central [Pyr1]apelin13 on LPS-induced fever in the rat</title><title>Regulatory peptides</title><addtitle>Regul Pept</addtitle><description>Intracerebroventricular (i.c.v.) injections of apelins have been shown to modulate the central control of cardiovascular function, as well as the homeostasis of fluid and salt balance, and to some extent also body core temperature. Here, we investigated the effects of i.c.v. administration of [Pyr1]apelin13 (PyrAp13; 20nmol) dissolved in artificial cerebrospinal fluid (aCSF), as compared to aCSF alone, on fever and sickness behavior elicited in rats by intraperitoneal injection of bacterial lipopolysaccharide (LPS, 100μg/kg). Injections of LPS induced a short phase of hypothermia followed by a biphasic fever, depression of motor activity, anorexia and adipsia. I.c.v. injections of PyrAp13 without systemic LPS application slightly augmented motor activity at statistically unaltered core temperature. In combination with LPS, central administration of PyrAp13 significantly reduced fever during the time period of 3–9h after injection, but did not significantly attenuate anorexia and adipsia, and had no effect on LPS-induced lethargy. Rats injected with PyrAp13 along with LPS showed a reduced level of LPS-induced circulating tumor necrosis factor-α (TNF-α). Primary neuroglial cultures established from the hypothalamic paraventricular nucleus (PVN) and the median preoptic nucleus (MnPO), brain sites being of major importance for central thermoregulation and also expressing the apelin receptor, were incubated with medium alone, medium containing LPS (100μg/ml) or LPS plus PyrAp13 (10−6mol/L). Ninety minutes after start of the incubation, LPS alone but not LPS in combination with PyrAp13 (10−6mol/L) caused a significant elevation of TNF-α in the supernatants. The novel observation that PyrAp13 represents a centrally acting endogenous antipyretic peptide is discussed in relation to its capacity to modulate peripheral and central formation of TNF-α. •Centrally applied [Pyr1]apelin13 attenuates LPS-induced fever in rats.•Centrally applied [Pyr1]apelin13 does not modulate food and water intake.•Centrally applied [Pyr1]apelin13 reduces LPS-induced circulating TNF-α.•Pyr1apelin13 reduces LPS-induced TNF-α release in hypothalamic microcultures.</description><subject>Animals</subject><subject>Antipyresis</subject><subject>Antipyretics - pharmacology</subject><subject>Antipyretics - therapeutic use</subject><subject>Apelin</subject><subject>Cytokines</subject><subject>Fever</subject><subject>Fever - drug therapy</subject><subject>Fever - metabolism</subject><subject>Fever - physiopathology</subject><subject>Hypothalamus</subject><subject>Injections, Intraperitoneal</subject><subject>Intercellular Signaling Peptides and Proteins - pharmacology</subject><subject>Intercellular Signaling Peptides and Proteins - therapeutic use</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Male</subject><subject>Paraventricular Hypothalamic Nucleus - metabolism</subject><subject>Rats</subject><subject>Sickness behavior</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><issn>0167-0115</issn><issn>1873-1686</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1Lw0AQhhdRbK3-A5E9ekmdyXazyUUoxS8oWFBPIkuymdUtaRJ300L_vSmtHoWBuTzvvMzD2CXCGAGTm-XY02dL7TgGFGPoB9MjNsRUiQiTNDlmwx5TESDKATsLYQmAUilxygaxkACpkEM2n9ada7eeOmc4WUum443lhurO5xV_X2w9fuQtVa5GwZuazxcvkavLtaGSW9qQ567m3Rdxn3fn7MTmVaCLwx6xt_u719ljNH9-eJpN55ERSdxFIpOEishAZosstioDzEyhyiwpqExKkiqfGCAFIpYiA0GSitgAxkqStIkYsev93dY332sKnV65YKiq8pqaddAopIDJBLK0Ryd71PgmBE9Wt96tcr_VCHrnUS_13qPeedTQD-5iV4eGdbGi8i_0K64HbvcA9X9uHHkdjKO6t-J871CXjfu_4QdG44R7</recordid><startdate>20130610</startdate><enddate>20130610</enddate><creator>Hatzelmann, Thomas</creator><creator>Harden, Lois M.</creator><creator>Roth, Joachim</creator><creator>Gerstberger, Rüdiger</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130610</creationdate><title>Antipyretic effect of central [Pyr1]apelin13 on LPS-induced fever in the rat</title><author>Hatzelmann, Thomas ; Harden, Lois M. ; Roth, Joachim ; Gerstberger, Rüdiger</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-395e17eec09fb92f79019cb7d96bed6de57a4c0e703253903e5eb2c01275e5f63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Antipyresis</topic><topic>Antipyretics - pharmacology</topic><topic>Antipyretics - therapeutic use</topic><topic>Apelin</topic><topic>Cytokines</topic><topic>Fever</topic><topic>Fever - drug therapy</topic><topic>Fever - metabolism</topic><topic>Fever - physiopathology</topic><topic>Hypothalamus</topic><topic>Injections, Intraperitoneal</topic><topic>Intercellular Signaling Peptides and Proteins - pharmacology</topic><topic>Intercellular Signaling Peptides and Proteins - therapeutic use</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Male</topic><topic>Paraventricular Hypothalamic Nucleus - metabolism</topic><topic>Rats</topic><topic>Sickness behavior</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hatzelmann, Thomas</creatorcontrib><creatorcontrib>Harden, Lois M.</creatorcontrib><creatorcontrib>Roth, Joachim</creatorcontrib><creatorcontrib>Gerstberger, Rüdiger</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Regulatory peptides</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hatzelmann, Thomas</au><au>Harden, Lois M.</au><au>Roth, Joachim</au><au>Gerstberger, Rüdiger</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antipyretic effect of central [Pyr1]apelin13 on LPS-induced fever in the rat</atitle><jtitle>Regulatory peptides</jtitle><addtitle>Regul Pept</addtitle><date>2013-06-10</date><risdate>2013</risdate><volume>184</volume><spage>6</spage><epage>13</epage><pages>6-13</pages><issn>0167-0115</issn><eissn>1873-1686</eissn><abstract>Intracerebroventricular (i.c.v.) injections of apelins have been shown to modulate the central control of cardiovascular function, as well as the homeostasis of fluid and salt balance, and to some extent also body core temperature. Here, we investigated the effects of i.c.v. administration of [Pyr1]apelin13 (PyrAp13; 20nmol) dissolved in artificial cerebrospinal fluid (aCSF), as compared to aCSF alone, on fever and sickness behavior elicited in rats by intraperitoneal injection of bacterial lipopolysaccharide (LPS, 100μg/kg). Injections of LPS induced a short phase of hypothermia followed by a biphasic fever, depression of motor activity, anorexia and adipsia. I.c.v. injections of PyrAp13 without systemic LPS application slightly augmented motor activity at statistically unaltered core temperature. In combination with LPS, central administration of PyrAp13 significantly reduced fever during the time period of 3–9h after injection, but did not significantly attenuate anorexia and adipsia, and had no effect on LPS-induced lethargy. Rats injected with PyrAp13 along with LPS showed a reduced level of LPS-induced circulating tumor necrosis factor-α (TNF-α). Primary neuroglial cultures established from the hypothalamic paraventricular nucleus (PVN) and the median preoptic nucleus (MnPO), brain sites being of major importance for central thermoregulation and also expressing the apelin receptor, were incubated with medium alone, medium containing LPS (100μg/ml) or LPS plus PyrAp13 (10−6mol/L). Ninety minutes after start of the incubation, LPS alone but not LPS in combination with PyrAp13 (10−6mol/L) caused a significant elevation of TNF-α in the supernatants. The novel observation that PyrAp13 represents a centrally acting endogenous antipyretic peptide is discussed in relation to its capacity to modulate peripheral and central formation of TNF-α. •Centrally applied [Pyr1]apelin13 attenuates LPS-induced fever in rats.•Centrally applied [Pyr1]apelin13 does not modulate food and water intake.•Centrally applied [Pyr1]apelin13 reduces LPS-induced circulating TNF-α.•Pyr1apelin13 reduces LPS-induced TNF-α release in hypothalamic microcultures.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>23500835</pmid><doi>10.1016/j.regpep.2013.03.018</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0167-0115
ispartof Regulatory peptides, 2013-06, Vol.184, p.6-13
issn 0167-0115
1873-1686
language eng
recordid cdi_proquest_miscellaneous_1353044098
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Animals
Antipyresis
Antipyretics - pharmacology
Antipyretics - therapeutic use
Apelin
Cytokines
Fever
Fever - drug therapy
Fever - metabolism
Fever - physiopathology
Hypothalamus
Injections, Intraperitoneal
Intercellular Signaling Peptides and Proteins - pharmacology
Intercellular Signaling Peptides and Proteins - therapeutic use
Lipopolysaccharides - pharmacology
Male
Paraventricular Hypothalamic Nucleus - metabolism
Rats
Sickness behavior
Tumor Necrosis Factor-alpha - metabolism
title Antipyretic effect of central [Pyr1]apelin13 on LPS-induced fever in the rat
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T13%3A09%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antipyretic%20effect%20of%20central%20%5BPyr1%5Dapelin13%20on%20LPS-induced%20fever%20in%20the%20rat&rft.jtitle=Regulatory%20peptides&rft.au=Hatzelmann,%20Thomas&rft.date=2013-06-10&rft.volume=184&rft.spage=6&rft.epage=13&rft.pages=6-13&rft.issn=0167-0115&rft.eissn=1873-1686&rft_id=info:doi/10.1016/j.regpep.2013.03.018&rft_dat=%3Cproquest_cross%3E1353044098%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1353044098&rft_id=info:pmid/23500835&rft_els_id=S0167011513000475&rfr_iscdi=true